ALKS vs VTR · P/E 14, rev $1.56B vs P/E 149, rev $4.92B
Alkermes Plc (ALKS) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ALKS and VTR stock pages for the full models.
Not investment advice.